The Schall Law Firm is organizing a class action lawsuit on behalf of investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025. The legal action follows the Securities and Exchange Commission's trading suspension of the company in November 2025, initiated after an investigation revealed irregularities in the company's stock performance during that period.
According to regulatory filings, Charming Medical's stock experienced a significant price surge that was attributed to coordinated promotional activity conducted through social media channels involving third-party advisors. The SEC determined that the stock movement lacked correlation to material company developments or legitimate business announcements, indicating potential market manipulation.
Investors who acquired MCTA securities during the specified timeframe are being encouraged to participate in the class action proceeding. Those interested in joining the lawsuit or obtaining additional information about their potential claims are being directed to contact the Schall Law Firm for legal consultation regarding eligible securities transactions.